GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk.
5 affiliations
- 1Chongqing Key Laboratory of Molecular Oncology and Epigenetics, Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
- 2Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China.
- 3Department of Radiology, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China.
- 4The Biobank of Southwest Hospital, The First Affiliated Hospital of Army Medical University, Chongqing 400038, China.
- 5Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing 401300, China.
Abstract
Background
Triple-negative breast cancer (TNBC) is exceptionally aggressive, with a high recurrence rate, resistance to chemotherapy, and a tendency to metastasize. The long non-coding RNA growth arrest-specific 5 (GAS5) is associated with TNBC progression; however, the specific mechanism still requires further exploration.Methods
Integrative bioinformatics analyses and qRT-PCR were used to investigate the significant downregulation of GAS5 in TNBC cells and tissues. The functional role and molecular mechanism of GAS5 in inhibiting the progression of TNBC and increasing sensitivity to chemotherapy were investigated using in vitro experiments, including qPCR, Western blot, CCK8 assay, Transwell, Chemotaxis assays, RNA immunoprecipitation, m6A-RNA immunoprecipitation, Chromatin immunoprecipitation, Flow cytometry, ELISA, and Luciferase reporter assays, and in vivo experiments using tumor xenografts.Results
GAS5 was significantly downregulated in TNBC cells and tissues, as well as in chemotherapy-resistant conditions. Functional assays revealed that overexpression of GAS5 attenuated the progression of TNBC and increased their sensitivity to docetaxel (DTX) both in vitro and in vivo. Furthermore, we confirmed that GAS5 recruited YTHDF2 to target MYBL2, which in turn downregulated the chemokine CCL2, which reduced the recruitment of myeloid-derived immunosuppressive cells (MDSCs). In addition, IL-6 from MDSCs downregulated GAS5 to promote TNBC growth and attenuate the sensitivity of TNBC to DTX through the STAT3/UPF1 axis, forming a feedback loop between tumor cells and MDSCs.Conclusions
These findings illustrated the significance of the GAS5-mediated mutual regulatory pathway between tumor cells and MDSCs in TNBC and provide new avenues for the development of targeted therapies in TNBC.
Related
- DUSP13 promotes prostate cancer progression by regulating the ERK1/2 pathway
- URGCP promotes osteosarcoma progression by regulating the ESCRT-III subunit CHMP4B
- CGRP remodels the acidic microenvironment and promotes pancreatic carcinoma progression by regulating NHE1 and CA9
- SPP1-CD44-Mediated Crosstalk Between Endothelial and Macrophage Subpopulations Promotes Pancreatic Ductal Adenocarcinoma Progression Through S100A6 Upregulation
- KAT2A Promotes the Progression of Renal Cell Carcinoma by Regulating the Succinylation of SERPINE2
BibTeX
@article{du2026gas5,
title = {{GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk.}},
author = {Junze Du and Xingyun He and Lingfeng Tang and Hao Liu and Qingqiu Chen and Sisi Li and Gang Tu and Shichao Li},
journal = {Cancers},
year = {2026},
month = sep,
doi = {10.3390/cancers18193133},
url = {https://europepmc.org/article/MED/42882828},
note = {CC BY},
}
RIS
TY - JOUR
TI - GAS5 Downregulation Promotes the Progression of Triple-Negative Breast Cancer by Regulating Tumor Cells-MDSCs Crosstalk.
AU - Junze Du
AU - Xingyun He
AU - Lingfeng Tang
AU - Hao Liu
AU - Qingqiu Chen
AU - Sisi Li
AU - Gang Tu
AU - Shichao Li
PY - 2026
DA - 2026/09/27
JO - Cancers
DO - 10.3390/cancers18193133
UR - https://europepmc.org/article/MED/42882828
AB - Background Triple-negative breast cancer (TNBC) is exceptionally aggressive, with a high recurrence rate, resistance to chemotherapy, and a tendency to metastasize. The long non-coding RNA growth arrest-specific 5 (GAS5) is associated with TNBC progression; however, the specific mechanism still requires further exploration.Methods Integrative bioinformatics analyses and qRT-PCR were used to investigate the significant downregulation of GAS5 in TNBC cells and tissues. The functional role and molecular mechanism of GAS5 in inhibiting the progression of TNBC and increasing sensitivity to chemotherapy were investigated using in vitro experiments, including qPCR, Western blot, CCK8 assay, Transwell, Chemotaxis assays, RNA immunoprecipitation, m6A-RNA immunoprecipitation, Chromatin immunoprecipitation, Flow cytometry, ELISA, and Luciferase reporter assays, and in vivo experiments using tumor xenografts.Results GAS5 was significantly downregulated in TNBC cells and tissues, as well as in chemotherapy-resistant conditions. Functional assays revealed that overexpression of GAS5 attenuated the progression of TNBC and increased their sensitivity to docetaxel (DTX) both in vitro and in vivo. Furthermore, we confirmed that GAS5 recruited YTHDF2 to target MYBL2, which in turn downregulated the chemokine CCL2, which reduced the recruitment of myeloid-derived immunosuppressive cells (MDSCs). In addition, IL-6 from MDSCs downregulated GAS5 to promote TNBC growth and attenuate the sensitivity of TNBC to DTX through the STAT3/UPF1 axis, forming a feedback loop between tumor cells and MDSCs.Conclusions These findings illustrated the significance of the GAS5-mediated mutual regulatory pathway between tumor cells and MDSCs in TNBC and provide new avenues for the development of targeted therapies in TNBC.
SN - 2072-6694
ER -